Panacea Life Sciences Holdings, Inc.
Balance Sheet
| Line Item | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $107.6K | $100.9K | $1.5K | $8.2K | $73.2K | $7.0K | $36.8K | $36.5K |
| Accounts Receivable | $270.9K | $264.0K | $308.8K | $272.1K | $274.8K | $206.1K | $221.9K | $219.6K |
| Inventory | $4.1M | $4.0M | $4.7M | $4.4M | $4.1M | $4.4M | $4.4M | $4.5M |
| Total Current Assets | $4.6M | $4.7M | $5.9M | $5.7M | $5.9M | $6.4M | $6.5M | $8.1M |
| Property, Plant & Equipment | $6.1M | $6.4M | $6.9M | $6.9M | $7.3M | $7.7M | $8.0M | $8.2M |
| Goodwill | $3.0M | $3.0M | $3.0M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M |
| Intangible Assets (Excl. Goodwill) | $3.0M | $3.0M | — | — | — | $2.2M | $15.4K | $30.7K |
| Total Assets | $17.4M | $18.0M | $18.7M | $17.9M | $18.6M | $19.5M | $20.0M | $22.0M |
| Liabilities | ||||||||
| Accounts Payable | $5.2M | $4.6M | $4.3M | $3.7M | $3.1M | $2.7M | $2.3M | $2.6M |
| Total Current Liabilities | $20.4M | $19.4M | $18.5M | $17.0M | $15.9M | $15.1M | $13.8M | $13.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $27.0M | $26.3M | $24.8M | $23.4M | $22.4M | $21.6M | $20.4M | $19.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-35.4M | $-33.9M | $-31.7M | $-29.6M | $-27.7M | $-25.9M | $-24.2M | $-21.5M |
| Total Stockholders' Equity | $-9.6M | $-8.3M | $-6.1M | $-5.6M | $-3.8M | $-2.1M | $-439.9K | $2.3M |